PHASE II TRIAL: CAPECETABINE (C) AND IRINOTECAN (I) (CAPIRI) AS FIRST-LINE CHEMOTHERAPY IN ELDERLY PATIENTS WITH ADVANCED COLORECTAL CANCER (ACRC)


    loading  Checking for direct PDF access through Ovid

Abstract

Abstract unavailable for this article.


    loading  Loading Related Articles